A new underground industry has emerged where people are buying raw compounds for Ozempic, Botox, filler and skin-tightening treatments directly from Chinese suppliers — and injecting them at ...

Sanofi's Sarclisa has played second fiddle to Johnson & Johnson's Darzalex in the treatment of multiple myeloma (MM), but the company hopes a new delivery option could give it more of a leading role.

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on procedural ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...